Histocompatibility complex (HLA)

The major histocompatibility complex (MHC) is the cell surface proteins, which are vital for the acquired immune system to identify foreign molecules in vertebrates, which in turn concludes histocompatibility. The chief purpose of MHC molecules is to bind to peptide fragments resulting from pathogens and exhibit them on the cell surface for recognition by the suitable T-cells. A MHC molecule enables the interactions of leukocytes, which are also known as white blood cells (WBCs), these are immune cells, with other leukocytes or with body cells. The MHC defines compatibility of contributors for organ transplant, as well as one's vulnerability to an autoimmune disease via cross reacting immunization. In humans, the MHC is also titled as the human leukocyte antigen (HLA).

    Related Conference of Histocompatibility complex (HLA)

    June 25-26, 2018

    2nd International Conference on Microbial Pathogenesis and Infectious Diseases

    Vancouver, Canada
    (10 Plenary Forums, 2 Days, 1 Event)
    June 20-21, 2018

    15th European Pathology Congress

    | Paris, France
    June 25-26, 2018

    15th CME Congress on Pathology and Cancer Research

    Vancouver, Canada
    August 29-30, 2018

    4th International Conference on Cytopathology & Histopathology

    Boston | Massachusetts | USA
    August 31 - September 01, 2018

    International Conference and Expo on Dermatopathology and Skin Diagnosis

    Toronto, Canada
    September 17-18,2018

    16th Annual Conference on Laboratory Medicine & Pathology

    Kuala Lumpur, Malaysia
    Sep 17-18, 2018

    16th Asia Pacific Pathology Congress

    Tokyo, Japan
    October 17-18, 2018

    2nd International Conference on Gynecology and Obstetrics Pathology

    Ottawa, Ontario, Canada
    October 18-19, 2018

    Biology and Pathology of Infectious Diseases Conference

    Helsinki, Finland

    Histocompatibility complex (HLA) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in